CTRI/2015/10/006250已完成不适用
to study complications of intraviteral injection of bevacizumab
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- To study ocular complications within a year of intravitreal injection of bevacizumab.
研究概览
简要总结
After considering for inclusion and exclusion criteria patients which were given intravitreal bevacizumab were recorded including their best corrected visual acuity, disease for which intravitreal injection was given number of injections given, slit lamp examination and fundus findings.
complications if any were recorded with its duration and management given for the same was also noted down.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •â€¢Age > 18 years •Any evidence of ocular neovascularisation, Choroidal neovasular membrane, macular edema due to retinal vein occlusion, diabetic retinopathy.
排除标准
- •â€¢Active external eye infection like conjunctivitis, meibomitis etc.
结局指标
主要结局
To study ocular complications within a year of intravitreal injection of bevacizumab.
时间窗: day1 and at 1 month
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
complications of injection given in the eye for retinal diseasesCTRI/2015/10/006250ETHRADHAMA SUPERSPECIALITY EYE HOSPITA100
已完成
3 期
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High MyopiaMyopiaChoroidal NeovascularizationNCT00967850Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA56
已完成
3 期
The study for the effect of intravitreous injection of ranibizumab (product name: Lucentis) and subthreshold laser photocoagulation on diabetic macular edemadiabetic macular edemaJPRN-UMIN000017037Jichi Medica University, Saitama Medical Center100
未知
不适用
Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on macular edema secondary to branch retinal vein occlusioMacular edema secondary to branch retinal vein occlusionJPRN-UMIN000001546Shiga University of Medical Science, department of Ophthalmology60
Unknown
1 期
Treatment for Presumed Ocular HistoplasmosisOcular HistoplasmosisNCT01790893John Kitchens, MD40